US Map / Idaho
State ID

Clinical Trials in Idaho

Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 41 actively recruiting studies with Idaho sites out of 41 registered in total. The busiest research areas in Idaho are Obesity, Asthma, Advanced Malignant Solid Neoplasm. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Vertex Pharmaceuticals Incorporated. By stage, Idaho trials break down as Phase 2 (10), Phase 3 (24).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
41
Recruiting Now
41
← Back to US Map
Top Conditions in Idaho
Obesity (2)Asthma (1)Advanced Malignant Solid Neoplasm (1)Anatomic Stage III Breast Cancer AJCC v8 (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Locally Advanced Malignant Solid Neoplasm (1)Malignant Female Reproductive System Neoplasm (1)Metastatic HER2-Negative Breast Carcinoma (1)Metastatic Malignant Solid Neoplasm (1)Recurrent Endometrial Carcinoma (1)Recurrent Fallopian Tube Carcinoma (1)Recurrent Malignant Female Reproductive System Neoplasm (1)

Frequently Asked Questions — Clinical Trials in Idaho

How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 41 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 41. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Obesity, Asthma, Advanced Malignant Solid Neoplasm, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Idaho

NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06390345 N/A
Recruiting
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise ...
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
400 pts
Location
United States
Sponsor
Seattle Institute for Biomedic
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT06983041 N/A
Recruiting
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Can...
Condition
Vulvovaginal Candidiasis (VVC)
Enrollment
55 pts
Location
United States
Sponsor
Coologics, Inc
View Trial →
NCT06740630 Phase 3
Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vacci...
Condition
Chickenpox
Enrollment
1,840 pts
Location
United States, Belgium, Colombia
Sponsor
GlaxoSmithKline
View Trial →
NCT07629440 Phase 3
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Condition
Pneumococcal Disease
Enrollment
3,230 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
View Trial →
NCT07723963 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment ...
Condition
Juvenile Myoclonic Epilepsy
Enrollment
260 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07028489 N/A
Recruiting
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or...
Condition
Non Small Cell Lung Cancer
Enrollment
130 pts
Location
United States
Sponsor
N-Power Medicine
View Trial →
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT07355062 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Me...
Condition
CKD
Enrollment
150 pts
Location
United States
Sponsor
Renibus Therapeutics, Inc.
View Trial →
NCT07504588 Phase 2
Recruiting
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplat...
Condition
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
Enrollment
87 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT04557462 Phase 3
Recruiting
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerabi...
Condition
Primary IgA Nephropathy
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
Page 1 of 2 — 41 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology